Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 4
2021 7
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19.
Abbasian L, Toroghi N, Rahmani H, Khalili H, Hasannezhad M, Ghiasvand F, Jafari S, Salehi M, Salahshour F, Azadbakhsh Kanaf Gorabi M, Alizade F, Ghaderkhani S, Nakhostin M. Abbasian L, et al. Among authors: ghaderkhani s. Int Immunopharmacol. 2022 Jun;107:108689. doi: 10.1016/j.intimp.2022.108689. Epub 2022 Mar 17. Int Immunopharmacol. 2022. PMID: 35313272 Free PMC article.
Rapid Detection Test for COVID-19 among Healthcare Workers and the Role of Personal Protective Equipment.
Hajiabdolbaghi M, Aryannejad A, Tabary M, Farhangi P, Abdollahi A, Ghaderkhani S, Amini M, Kimyaee E, Ranjbar A, Salehi M, Ghiasvand F, Meidani M, Hasannezhad M, Mohammadnejad E, Hadipour M, Araghi F, Mashinchi B, Seifi A. Hajiabdolbaghi M, et al. Among authors: ghaderkhani s. Arch Iran Med. 2022 Feb 1;25(2):91-97. doi: 10.34172/aim.2022.15. Arch Iran Med. 2022. PMID: 35429945 Free article.
Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study.
SeyedAlinaghi S, Abbasian L, Solduzian M, Ayoobi Yazdi N, Jafari F, Adibimehr A, Farahani A, Salami Khaneshan A, Ebrahimi Alavijeh P, Jahani Z, Karimian E, Ahmadinejad Z, Khalili H, Seifi A, Ghiasvand F, Ghaderkhani S, Rasoolinejad M. SeyedAlinaghi S, et al. Among authors: ghaderkhani s. Eur J Med Res. 2021 May 6;26(1):41. doi: 10.1186/s40001-021-00513-x. Eur J Med Res. 2021. PMID: 33957992 Free PMC article.
COVID-19, An early investigation from exposure to treatment outcomes in Tehran, Iran.
Ashraf MA, Shokouhi N, Shirali E, Davari-Tanha F, Shirani K, Memar O, Kamalipour A, Azarnoush A, Mabadi A, Ossareh A, Sanginabadi M, Azad TM, Aghaghazvini L, Ghaderkhani S, Poordast T, Pourdast A, Nazemi P. Ashraf MA, et al. Among authors: ghaderkhani s. J Res Med Sci. 2021 Nov 29;26:114. doi: 10.4103/jrms.JRMS_1088_20. eCollection 2021. J Res Med Sci. 2021. PMID: 35126577 Free PMC article.
Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study.
Khorshiddoust RR, Khorshiddoust SR, Hosseinabadi T, Mottaghitalab F, Mokhtari F, Azadinia F, Mozdarani H, Shabani M, Emadi-Kouchak H, Taheri B, Khani-Juyabad F, Kashani MA, Sadoughi A, Zamanizadeh S, Maddah H, Aminzadeh M, Khanaki M, Saremi S, Rad AP, Fatehi A, Rad MG, Haftbaradaran M, Khosroshahi M, Sadeghi M, Aminnayeri M, Jafari S, Ghiasvand F, Seifi A, Ghaderkhani S, Manshadi SAD, Salehi M, Abbasian L, Hasannezhad M, Meidani M, Hajiabdolbaghi M, Ahmadinejad Z, Parash M, Sedighi Z, Mohammadian A. Khorshiddoust RR, et al. Among authors: ghaderkhani s. Biomed Pharmacother. 2022 May;149:112729. doi: 10.1016/j.biopha.2022.112729. Epub 2022 Feb 17. Biomed Pharmacother. 2022. PMID: 35276467 Free PMC article. Clinical Trial.
18 results